Trends in gut-heart axis and heart failure research (1993-2023): A bibliometric and visual analysis

Jiahui Ouyang1,2, Lingli Zhao1,2, Yewen Song1

  • 1Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.

Heliyon
|February 26, 2024
PubMed

Insights

Research on the gut-heart axis and heart failure is rapidly growing. Key areas include gut microbiota, trimethylamine N-oxide, inflammation, and short-chain fatty acids, representing emerging trends in cardiovascular disease research.

Area of Science:

  • Cardiovascular Research
  • Microbiome Science
  • Bibliometrics

Background:

  • Heart failure incidence is rising globally due to aging populations.
  • The gut-heart axis, involving bidirectional communication, significantly impacts heart failure.
  • Understanding this axis is crucial for managing cardiovascular diseases.

Purpose of the Study:

  • To conduct a bibliometric analysis of research on the gut-heart axis and heart failure.
  • To identify key trends, influential works, and future research directions in this field.

Main Methods:

  • Literature search in the Web of Science Core Collection (1993-2023).
  • Bibliometric and visualization analyses using CiteSpace, VOSviewer, and R.
  • Analysis of publication trends, author contributions, institutions, and keywords.

Main Results:

  • 1646 articles published, with a notable increase since 2018.
  • USA and China are leading countries; Cleveland Clinic and Charité-Universitätsmedizin Berlin are top institutions.
  • "Heart failure," "gut microbiota," "trimethylamine N-oxide," and "inflammation" are prominent keywords.
  • Emerging research focuses on "gut microbiota" and "short-chain fatty acids."

Conclusions:

  • Research on the gut-heart axis and heart failure is expanding significantly.
  • Gut microbiota, trimethylamine N-oxide, inflammation, and short-chain fatty acids are key emerging research areas.
  • This analysis provides insights into current research landscapes and future directions for the gut-heart axis in heart failure.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.6K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
941
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431